Prenatal Sample Requirements

Baylor Genetics accepts the following sample types for prenatal tests. Submitted sample types must meet the sample requirements for all ordered prenatal testing. For assistance with billing questions, kit requests, and/or shipping, please call 1-800-411-4363. Genetic counselors may be reached via email at gc@baylorgenetics.com for test inquiries. Shipping and labeling instructions can be found at the bottom of the page.

Prenatal Cytogenetic Testing

Prenatal Tests Specimen Type Quanity Required Additional Required Samples
Direct Cultured Extracted DNA
Prenatal  Chromosome Analysis, Array Analysis, or Array + Limited Chromosome Analysis CVS
Test Codes: 8700, 8657, 8671, 8672, 8676
15+ mg CVS in sterile tissue culture media 1 T-25 flask at about 80% confluency For Array Analysis Only:
20ug of purified DNA (minimal concentration of 50ng/uL; A260/A280 of ~1.7)
For Array Analysis Only:
Maternal required and paternal preferred for array analysis
Amniotic Fluid
Test Codes: 8530, 8656, 8670, 8673, 8675
20-30 cc of fluid in two sterile 15 mL conical centrifuge tubes. Discard the first 2 cc of fluid collected. 1 T-25 flask at about 80% confluency
FISH Analysis – Prenatal Aneuploidy
Test Code: 8410
CVS 15+ mg CVS in sterile tissue culture media N/A N/A N/A
Amniotic Fluid 20-30 cc of fluid in two sterile 15 mL conical centrifuge tubes. Discard the first 2 cc of fluid collected. N/A N/A

Prenatal Whole Exome Sequencing

Prenatal Tests Specimen Type Quanity Required Additional Required Samples
Direct Cultured Extracted DNA
Prenatal Trio Whole Exome Sequencing
Test Code: 1622
CVS 15+ mg CVS in sterile tissue culture media 2 T-25 flask at about 80% confluency from separate primaries 20ug of purified DNA (minimal concentration of 50ng/uL; A260/A280 of ~1.7) Maternal and paternal required
Amniotic Fluid 20-30 cc of fluid in two sterile 15 mL conical centrifuge tubes. Discard the first 2 cc of fluid collected. 2 T-25 flask at about 80% confluency from separate primaries

Prenatal Molecular

Prenatal Tests Specimen Type Quanity Required Additional Required Samples
Direct Cultured Extracted DNA
Custom Sequence Analysis
Test Code: 1522
CVS 15+ mg CVS in sterile tissue culture media 2 T-25 flask at about 80% confluency from separate primaries 20ug of purified DNA (minimal concentration of 50ng/uL; A260/A280 of ~1.7) Maternal and positive control required
Amniotic Fluid 20-30 cc of fluid in two sterile 15 mL conical centrifuge tubes. Discard the first 2 cc of fluid collected. 2 T-25 flask at about 80% confluency from separate primaries
DMD Deletion/Duplication
Test Code: 6351
CVS 15+ mg CVS in sterile tissue culture media 2 T-25 flask at about 80% confluency from separate primaries Maternal and positive control required
Amniotic Fluid 20-30 cc of fluid in two sterile 15 mL conical centrifuge tubes. Discard the first 2 cc of fluid collected. 2 T-25 flask at about 80% confluency from separate primaries
Myotonic Dystrophy Type 1 Repeat Expansion Analysis
Test Code: 6105
CVS 15+ mg CVS in sterile tissue culture media 2 T-25 flask at about 80% confluency from separate primaries Maternal and positive control required
Amniotic Fluid 20-30 cc of fluid in two sterile 15 mL conical centrifuge tubes. Discard the first 2 cc of fluid collected. 2 T-25 flask at about 80% confluency from separate primaries
Huntington Disease Repeat Expansion Analysis
Test Code: 6099
CVS 15+ mg CVS in sterile tissue culture media 2 T-25 flask at about 80% confluency from separate primaries Maternal and positive control required
Amniotic Fluid 20-30 cc of fluid in two sterile 15 mL conical centrifuge tubes. Discard the first 2 cc of fluid collected. 2 T-25 flask at about 80% confluency from separate primaries
FMR1 (Fragile X) CGG Repeat Expansion Analysis
Test Code: 6574
Amniotic Fluid
20-30 cc of fluid in two sterile 15 mL conical centrifuge tubes. Discard the first 2 cc of fluid collected. 2 T-25 flask at about 80% confluency from separate primaries Maternal required and paternal preferred
MECP2 (Rett Syndrome) Deletion/Duplication
Test Code: 6109
CVS 15+ mg CVS in sterile tissue culture media 2 T-25 flask at about 80% confluency from separate primaries Maternal and positive control required
Amniotic Fluid 20-30 cc of fluid in two sterile 15 mL conical centrifuge tubes. Discard the first 2 cc of fluid collected. 2 T-25 flask at about 80% confluency from separate primaries
IKBKG (Incontinentia Pigmenti) Common Deletion Analysis
Test Code: 6100
CVS 15+ mg CVS in sterile tissue culture media 2 T-25 flask at about 80% confluency from separate primaries Maternal and positive control required
Amniotic Fluid 20-30 cc of fluid in two sterile 15 mL conical centrifuge tubes. Discard the first 2 cc of fluid collected. 2 T-25 flask at about 80% confluency from separate primaries
Prenatal Noonan Spectrum Disorders/RASopathy Panel
Test Code: 24001-P12-05
CVS 15+ mg CVS in sterile tissue culture media 2 T-25 flask at about 80% confluency from separate primaries Maternal required
Amniotic Fluid 20-30 cc of fluid in two sterile 15 mL conical centrifuge tubes. Discard the first 2 cc of fluid collected. 2 T-25 flask at about 80% confluency from separate primaries

Other Prenatal

Prenatal Tests Specimen Type Quanity Required Additional Required Samples
Direct Cultured Extracted DNA
Alpha-fetoprotein and Acetylcholinesterase Analysis
Test Code: 8550
Amniotic Fluid Collect at least 3 mL amniotic fluid in a sterile leak-proof container.
N/A N/A N/A
Alphafetoprotein Analysis
Test Code: 8501
Amniotic Fluid Collect at least 3 mL amniotic fluid in a sterile leak-proof container.
N/A
Herpes Simplex Virus 1 & 2 Analysis
Test Code: 8940
Amniotic Fluid Collect 1 mL amniotic fluid in a sterile leak-proof container.
N/A
Cytomegalovirus (CMV) Analysis
Test Code: 8945
Amniotic Fluid Collect 1 mL amniotic fluid in a sterile leak-proof container.
N/A
Toxoplasma gondii (TOXO) Analysis
Test Code: 8950
Amniotic Fluid Collect 1 mL amniotic fluid in a sterile leak-proof container.
N/A
Parvovirus B19 Analysis
Test Code: 8955
Amniotic Fluid Collect 1 mL amniotic fluid in a sterile leak-proof container.
N/A

Products of Conception (POC)

Tests Specimen Type Quanity Required Additional Required Samples
Direct Cultured Extracted DNA
Chromosome Analysis Test Code: 8800

 

and

 

Chromosomal Microarray Analysis Test Code: 8639

Unclotted Cord or Cardiac Blood For Chromosome Analysis:
Draw 3-5 cc blood in Sodium Heparin (green-top) tube(s).For Array Analysis:
Draw 3-5 cc blood in an EDTA (purple-top) tube(s).
N/A For Array Analysis Only:
20ug of purified DNA (minimal concentration of 50ng/uL; A260/A280 of ~1.7)
For Array Analysis Only:
Maternal and paternal preferred
Placenta Collect 10 cubic millimeters placenta from fetal side near the site of cord insertion. Place sample in a separate sterile container with RPMI media. In the absence of RPMI media, place sample in a sterile container with a small amount of sterile saline. Never place samples in formalin or other fixative.
N/A
Identifiable Fetal Parts Collect 5 cubic millimeters of sample in a separate sterile container with RPMI media. In the absence of RPMI media, place sample in a sterile container with a small amount of sterile saline. Never place samples in formalin or other fixative.
N/A
Chorionic Villi or Non-Fixed Tissue Please send at least 50-100 mg villi or 0.5 – 1 cm3 tissue(s) in a sterile container with either sterile: 1. Transport media provided by our laboratory, 2. Ringer’s lactate, or 3. Hanks’ balanced salt solution.
N/A
Cultured Skin Fibroblast N/A
1-2 T25 flasks at 80-100% confluence.
Cultured Tissue N/A
1-2 T25 flasks at 80-100% confluence.
Other
Other Please contact the laboratory to discuss other test codes and specimen types that may be acceptable for products of conception.

Shipping Instructions:
Ship the sample at room temperature to the laboratory by overnight express. Specimen should arrive in the laboratory within 48 hrs of sample date. Do not heat or freeze.

Labeling:
For prenatal testing, please make sure that the specimen containers have two identifiers that match the prenatal test requisition. Identifiers include, but are not limited to, the following:

Patient’s First and Last Name
Date of Birth
Accession #
Hospital / Medical Record #